Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	AGE-RAGE signaling pathway in diabetic complications	2/100	0.006399778215208473	0.08630067111205773	20.331632653061224	-27.120602948412195	CDKN1B;TGFB1
KEGG_2021_Human	Osteoclast differentiation	2/127	0.010161324318032567	0.08630067111205773	15.886	-21.510038502238015	TGFB1;TNFSF11
KEGG_2021_Human	Gastric cancer	2/149	0.013800829937106646	0.08630067111205773	13.47108843537415	-18.28530462280935	CDKN1B;TGFB1
KEGG_2021_Human	FoxO signaling pathway	2/131	0.010785539693571716	0.08630067111205773	15.385658914728682	-20.853034219946885	CDKN1B;TGFB1
KEGG_2021_Human	Renal cell carcinoma	2/69	0.0030959091544989293	0.08630067111205773	29.854477611940297	-38.032897794694755	FH;TGFB1
KEGG_2021_Human	Cushing syndrome	2/155	0.014879426053803059	0.08630067111205773	12.933006535947712	-17.54750234216727	CDKN1B;FH
KEGG_2021_Human	Chronic myeloid leukemia	2/76	0.0037436519554145367	0.08630067111205773	27.006756756756758	-34.90410589940028	CDKN1B;TGFB1
KEGG_2021_Human	Rheumatoid arthritis	2/93	0.005556617161068888	0.08630067111205773	21.914835164835164	-29.03004575134454	TGFB1;TNFSF11
KEGG_2021_Human	Breast cancer	2/147	0.013449368234662449	0.08630067111205773	13.660344827586206	-18.543070369415922	PGR;TNFSF11
KEGG_2021_Human	Cell cycle	2/124	0.009704304916610982	0.08630067111205773	16.2827868852459	-22.027132854342252	CDKN1B;TGFB1
KEGG_2021_Human	Transcriptional misregulation in cancer	2/192	0.0223068963273402	0.11567528504923057	10.365789473684211	-13.920708621090329	CDKN1B;HMGA2
KEGG_2021_Human	Pathways in cancer	3/531	0.02393281759639253	0.11567528504923057	6.12012987012987	-11.164029011261546	CDKN1B;FH;TGFB1
KEGG_2021_Human	Chemical carcinogenesis	2/239	0.03354092254711208	0.14964411597942312	8.26054852320675	-10.803362590978235	PGR;TNFSF11
KEGG_2021_Human	Citrate cycle (TCA cycle)	1/30	0.03654338399736008	0.1513940194176346	30.800766283524904	-16.574318247175444	FH
KEGG_2021_Human	SNARE interactions in vesicular transport	1/33	0.040130782413471976	0.15517235866542498	27.90277777777778	-15.299431750604054	BET1L
KEGG_2021_Human	MicroRNAs in cancer	2/310	0.0538910819803677	0.1746764575056847	6.298701298701299	-7.775300015246377	CDKN1B;HMGA2
KEGG_2021_Human	Pyruvate metabolism	1/47	0.05671353920929476	0.1746764575056847	19.3768115942029	-11.24402387762608	FH
KEGG_2021_Human	Cytokine-cytokine receptor interaction	2/295	0.04928069612200721	0.1746764575056847	6.6339590443686	-8.300944532041967	TGFB1;TNFSF11
KEGG_2021_Human	Intestinal immune network for IgA production	1/48	0.05788809587819119	0.1746764575056847	18.962174940898347	-11.032973182262484	TGFB1
KEGG_2021_Human	Malaria	1/50	0.060233261208856796	0.1746764575056847	18.183673469387756	-10.63265628196324	TGFB1
KEGG_2021_Human	HIF-1 signaling pathway	1/109	0.1270956407872156	0.19389556953005604	8.189300411522634	-4.893732148578802	CDKN1B
KEGG_2021_Human	Chagas disease	1/102	0.11939326812281527	0.19389556953005604	8.764576457645765	-5.262086311101535	TGFB1
KEGG_2021_Human	Colorectal cancer	1/86	0.10155766145487406	0.19389556953005604	10.435294117647059	-6.300464747037211	TGFB1
KEGG_2021_Human	Amoebiasis	1/102	0.11939326812281527	0.19389556953005604	8.764576457645765	-5.262086311101535	TGFB1
KEGG_2021_Human	Hypertrophic cardiomyopathy	1/90	0.10604677818396174	0.19389556953005604	9.961298377028713	-6.010407578745034	TGFB1
KEGG_2021_Human	Inflammatory bowel disease	1/65	0.07765521083230079	0.19389556953005604	13.895833333333334	-8.322075559905016	TGFB1
KEGG_2021_Human	ErbB signaling pathway	1/85	0.10043221696214563	0.19389556953005604	10.56084656084656	-6.37671991533167	CDKN1B
KEGG_2021_Human	Dilated cardiomyopathy	1/96	0.11274260878642009	0.19389556953005604	9.32514619883041	-5.615549699272252	TGFB1
KEGG_2021_Human	Leishmaniasis	1/77	0.09138288226635771	0.19389556953005604	11.68421052631579	-7.04872976578505	TGFB1
KEGG_2021_Human	TGF-beta signaling pathway	1/94	0.11051569770952978	0.19389556953005604	9.528076463560334	-5.7422174156532195	TGFB1
KEGG_2021_Human	Pancreatic cancer	1/76	0.09024597396088518	0.19389556953005604	11.841481481481482	-7.141387005986298	TGFB1
KEGG_2021_Human	Parathyroid hormone synthesis, secretion and action	1/106	0.12380207979004104	0.19389556953005604	8.426455026455027	-5.046288872333345	TNFSF11
KEGG_2021_Human	Th17 cell differentiation	1/107	0.1249011740201087	0.19389556953005604	8.345911949685535	-4.994589105830365	TGFB1
KEGG_2021_Human	Progesterone-mediated oocyte maturation	1/100	0.11718138394436346	0.19389556953005604	8.94388327721661	-5.375723879218761	PGR
KEGG_2021_Human	Prolactin signaling pathway	1/70	0.08339759626885078	0.19389556953005604	12.880837359098228	-7.74542097629872	TNFSF11
KEGG_2021_Human	Prostate cancer	1/97	0.11385418156418702	0.19389556953005604	9.226851851851851	-5.553951626329874	CDKN1B
KEGG_2021_Human	Small cell lung cancer	1/92	0.10828375753966943	0.19389556953005604	9.739926739926739	-5.8737398650795125	CDKN1B
KEGG_2021_Human	Toxoplasmosis	1/112	0.13037805537365837	0.19389556953005604	7.964964964964965	-4.748494648054986	TGFB1
KEGG_2021_Human	NF-kappa B signaling pathway	1/104	0.12160016340314761	0.19389556953005604	8.592233009708737	-5.152341092635986	TNFSF11
KEGG_2021_Human	Thyroid hormone signaling pathway	1/121	0.14015875566728583	0.20323019571756445	7.359259259259259	-4.351741094826131	MED12
KEGG_2021_Human	Relaxin signaling pathway	1/129	0.1487694756391342	0.2054435615968996	6.892361111111111	-4.041189892105298	TGFB1
KEGG_2021_Human	Oocyte meiosis	1/129	0.1487694756391342	0.2054435615968996	6.892361111111111	-4.041189892105298	PGR
KEGG_2021_Human	Measles	1/139	0.15942370386618251	0.21014942782360424	6.384863123993559	-3.698840756963446	CDKN1B
KEGG_2021_Human	Estrogen signaling pathway	1/137	0.15730251033809037	0.21014942782360424	6.480392156862745	-3.763669230249352	PGR
KEGG_2021_Human	Cellular senescence	1/156	0.17726075583432344	0.22294458866931569	5.672401433691756	-3.209640069203435	TGFB1
KEGG_2021_Human	Non-alcoholic fatty liver disease	1/155	0.17622102470306392	0.22294458866931569	5.70995670995671	-3.235678410841787	TGFB1
KEGG_2021_Human	Hepatitis B	1/162	0.18347437883820783	0.22294458866931569	5.456866804692892	-3.0596637281364782	TGFB1
KEGG_2021_Human	Hippo signaling pathway	1/163	0.1845058664849509	0.22294458866931569	5.422496570644719	-3.0356632226338247	TGFB1
KEGG_2021_Human	Hepatocellular carcinoma	1/168	0.18964573513289215	0.22447862525934173	5.256819693945443	-2.919648521708157	TGFB1
KEGG_2021_Human	Tuberculosis	1/180	0.20186266926868635	0.23416069635167616	4.896958410924891	-2.6658400097237527	TGFB1
KEGG_2021_Human	Proteoglycans in cancer	1/205	0.22678373523038298	0.2435825304326336	4.283224400871459	-2.2275706216550177	TGFB1
KEGG_2021_Human	Epstein-Barr virus infection	1/202	0.22383065271253133	0.2435825304326336	4.3488114980652295	-2.274707784911856	CDKN1B
KEGG_2021_Human	Diabetic cardiomyopathy	1/203	0.22481613944093093	0.2435825304326336	4.326732673267327	-2.2588473265567357	TGFB1
KEGG_2021_Human	Viral carcinogenesis	1/203	0.22481613944093093	0.2435825304326336	4.326732673267327	-2.2588473265567357	CDKN1B
KEGG_2021_Human	Human T-cell leukemia virus 1 infection	1/219	0.24043153000367978	0.2535459770947896	4.001019367991845	-2.0240281738454993	TGFB1
KEGG_2021_Human	MAPK signaling pathway	1/294	0.3099217585428667	0.32099039277654046	2.9484262419416005	-1.2588658824557653	TGFB1
KEGG_2021_Human	Human papillomavirus infection	1/331	0.3420488957114324	0.3480497535309312	2.6053872053872054	-1.0106876845884132	CDKN1B
KEGG_2021_Human	PI3K-Akt signaling pathway	1/354	0.36133488698431165	0.36133488698431165	2.4283915643689014	-0.883914601009246	CDKN1B
